Introduction {#s0001}
============

Increasing incidence of end-stage renal disease (ESRD) and its associated morbidity is a serious worldwide public health problem. According to the 2017 US Renal Data System (USRDS) Annual Data Report, the number of new ESRD cases in the United States was 124 111 in 2015 \[[@CIT0001]\]. So, with the increasing ESRD cases, the demand for renal replacement therapy (RRT) is increasing year by year. The choice of predominant method of RRT varies in different countries. In China, about 86% of the dialysis population receive hemodialysis (HD) \[[@CIT0002]\], and about 72.8%, 84% of the dialysis population receive HD in Zhejiang province, Shanghai of China, respectively \[[@CIT0002],[@CIT0003]\]. HD is still considered as a major treatment choice for patients in Sichuan province in southwest of China, and receive HD twice or thrice weekly.

The number of patients requiring dialysis is rapidly increasing in the past 10 years, but HD is an expensive treatment modality that lays a heavy burden on the national healthcare cost. In China, the ERSD patients are increasing by 120 thousand each year, which requires more than 1.4 billion dollars for the maintenance of their survival and treatment. This accounted for 1--3% of national healthcare costs and presented consecutive stress on the nation's health foundation \[[@CIT0004]\].

Hence, it is imperative to understand the incidence, pathogenesis and mortality rate in end-stage renal disease patients with hemodialysis (ESRD-HD) patients according to gender and age from 2011 to 2016 in Sichuan province. Our results are considered important for the government to deal with the increasing burden of patients with ESRD-HD.

Clinical materials and methodology {#s0002}
==================================

Data sources and ethnics {#s0003}
------------------------

The Chinese National Renal Data System (CNRDS) is initiated by the Chinese Society of Nephrology under the lead of the Ministry of Health of China in 2010. The main objectives of the CNRDS include collection of demographic, clinical and laboratory data of HD and peritoneal dialysis (PD) cases to establish a kidney disease database for research and policy making \[[@CIT0002]\]. The data for retrospective analysis were exported from the CNRDS, including new, long-term and dead ESRD-HD patients from 01 January 2011 to 31 December 2016 in south west of China, Sichuan province. This study was approved by the Hospital Human Research Ethics Committee of Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (No. 2017-120).

Analyzed indexes {#s0004}
----------------

This was a retrospective descriptive study. All the demographic and pathogenic information of the patients with ESRD-HD were extracted from the CNRDS, which included the demographics of ESRD-HD patient's, primary causes as well as the death rates of ESRD-HD patient's, along with the causes of death. Analysis included annual morbidity, gender differences, and pathogenesis, as well as mortality rates and causes. The comparison and differences between different sexes and ages were emphatically analyzed by statistical methods.

The annual incidence was calculated as the number of new patients undergoing HD between 1 January and 31 December divided by the provincial resident population. The obtained value was expressed as per million population (pmp).

The mortality rates (per 1000 person years) were calculated as the number of HD deaths between 1 January and 31 December divided by mid-year prevalent dialysis patients (the number of prevalent dialysis patients at the end of year (*x* -- 1)) + (the number of prevalent dialysis patients at the end of year *x*)/2.

Statistical methodology {#s0005}
-----------------------

Statistical analysis of the data was performed by using SAS (version 9.3, Cary, NC). The measurement data were expressed as mean ± standard deviation. Enumeration data were expressed as case numbers (percent). Comparison between the two groups was done by using Chi square test or Fisher's exact test. *p* Values of \<.05 were considered to be statistically significant.

Results {#s0006}
=======

Patient characteristics of incident ESRD-HD {#s0007}
-------------------------------------------

According to the data from CNRDS, there were 33 632 patients with an incidence of ESRD-HD from 01 January 2011 to 31 December 2016. The incidence of ESRD-HD annually was 61.84, 73.75, 78.04, 66.04, 72.61, and 60.98 pmp each year, respectively ([Table 1](#t0001){ref-type="table"}).

###### 

The incidence of initial ESRD-HD patients from 2011 to 2016 in Sichuan province (pmp).

  Year                                    2011    2012    2013    2014    2015    2016
  --------------------------------------- ------- ------- ------- ------- ------- -------
  Initial ESRD-HD patients                4978    5956    6327    5376    5957    5038
  Resident population (million)           80.50   80.76   81.07   81.40   82.04   82.62
  Incidence of ESRD-HD (pmp)              61.84   73.75   78.04   66.04   72.61   60.98
  Initial ESRD-HD patients (male)         2989    3603    3758    3140    3526    2981
  Resident population (million, male)     41.12   42.3    41.33   40.34   41.20   41.37
  Incidence of ESRD-HD (pmp, male)        72.69   85.18   90.93   77.84   85.58   72.06
  Initial ESRD-HD patients (female)       1989    2353    2569    2236    2431    2057
  Resident population (million, female)   39.38   38.46   39.74   41.06   40.84   41.25
  Incidence of ESRD-HD (pmp, female)      50.51   61.18   64.65   54.46   59.53   49.87

Of the total incident HD patients, males accounted for 19 997 and females accounted for 13 635, with a ratio of 1.5:1 (male:female). The incidence of ESRD-HD patients undergoing HD was higher in males than in females (*p* \< .05, [Table 1](#t0001){ref-type="table"}).

There were 32 952 HD patients with complete information of age, accounting for 98.0% of the total. It was also noted that the middle age and elder group contributed to most of the incidence of HD patients ([Table 2](#t0002){ref-type="table"}).

###### 

The incidence of ESRD-HD in patients by different ages from 2011 to 2016 in Sichuan province (%).

  Age/year   2011           2012           2013           2014           2015           2016           2011--2016
  ---------- -------------- -------------- -------------- -------------- -------------- -------------- ------------
  \<18       28 (0.6%)      31 (0.5%)      55 (0.9%)      23 (0.4%)      18 (0.3%)      23 (0.5%)      178
  18--29     429 (9.1%)     565 (9.7%)     531 (8.4%)     398 (7.5%)     430 (7.3%)     303 (6.2%)     2656
  30--39     749 (15.9%)    845 (14.4%)    775 (12.3%)    545 (10.3%)    535 (9.1%)     431 (8.7%)     3880
  40--49     1116 (23.7%)   1446 (24.7%)   1533 (24.4%)   1292 (24.3%)   1336 (22.8%)   1023 (20.8%)   7746
  50--59     764 (16.2%)    938 (16.0%)    1047 (16.7%)   995 (18.7%)    1131 (19.3%)   1049 (21.3%)   5924
  60--69     892 (19.0%)    1092 (18.7%)   1297 (20.6%)   1142 (21.5%)   1281 (21.8%)   1108 (22.5%)   6812
  70--79     587 (12.5%)    741 (12.7%)    818 (13.0%)    725 (13.7%)    889 (15.2%)    790 (16.0%)    4550
  ≥80        140 (3.0%)     193 (3.3%)     233 (3.7%)     192 (3.6%)     245 (4.2%)     203 (4.1%)     1206
  Total      4705           5851           6289           5312           5865           4930           32 952

Pathogenesis analysis of incident ESRD-HD patients {#s0008}
--------------------------------------------------

Among the 33 632 incident ESRD-HD patients, there were 29 447 cases with complete information of pathogenesis, accounting for 87.7% of the total. The major causes of incident ESRD-HD included chronic glomerulonephritis, diabetic nephropathy, and hypertensive nephrosclerosis. The percentage of chronic glomerulonephritis was gradually descending annually, whereas the percentage of diabetic nephropathy was ascending ([Figure 1](#F0001){ref-type="fig"}).

![The pathogenesis analysis incidence of ESRD-HD patients from 2011 to 2016 in Sichuan province (%).](IRNF_A_1612429_F0001_C){#F0001}

*Other*: Obstructive nephropathy, drug-induced renal injury, hereditary kidney disease, hyperuricemia, and so on.

Mortality analysis of ESRD-HD patients {#s0009}
--------------------------------------

According to the data from CNRDS, there were 8285 deaths from 01 January 2011 to 31 December 2016 in Sichuan province of China. The annual mortality rate of ESRD-HD patients was 113.20, 91.25, 73.02, 68.56, 68.57, and 58.39 per 1000 person-years from 2011 to 2016. The descending rate of mortality was parallel in both males and females ([Table 3](#t0003){ref-type="table"}).

###### 

The mortality of ESRD-HD patients and from 2011 to 2016 in Sichuan province (per 1000 person-years).

  Year                                                       2011     2012     2013     2014     2015     2016
  ---------------------------------------------------------- -------- -------- -------- -------- -------- --------
  ESRD-HD patients                                           10 248   13 425   17 310   20 830   23 948   26 820
  Death number of ESRD-HD patients                           1160     1225     1264     1428     1642     1566
  Mortality rate of ESRD-HD (per 1000 person-years)          113.20   91.25    73.02    68.56    68.57    58.39
  ESRD-HD patients (male)                                    6070     8033     10 307   12 378   14 232   15 940
  Death number of ESRD-HD patients (male)                    675      722      766      820      931      936
  Mortality rate of ESRD-HD (male.per 1000 person-years)     111.2    89.89    74.32    66.25    65.42    58.72
  ESRD-HD patients (female)                                  4178     5441     7003     8452     9716     10 880
  Death number of ESRD-HD patients (female)                  485      503      498      608      711      630
  Mortality rate of ESRD-HD (female.per 1000 person-years)   116.08   92.45    71.11    71.94    73.18    57.9

Among all the dead patients (8285), 7828 cases (80.0%) completely registered their age. Most of the deaths were encountered in the elderly group (age ≥ 60) ([Table 4](#t0004){ref-type="table"}).

###### 

The constitution of dead ESRD-HD patients by different ages from 2011 to 2016 in Sichuan province (%).

  Age/year   2011          2012          2013          2014          2015          2016          2011--2016
  ---------- ------------- ------------- ------------- ------------- ------------- ------------- ------------
  \<18       2 (0.2%)      1 (0.1%)      2 (0.2%)      3 (0.2%)      3 (0.2%)      2 (0.1%)      13
  18--29     40 (4.1%)     44 (3.8%)     30 (2.5%)     36 (2.6%)     31 (2.0%)     28 (1.9%)     209
  30--39     91 (9.2%)     84 (7.3%)     71 (5.8%)     53 (3.8%)     68 (4.3%)     43 (2.9%)     410
  40--49     174 (17.7%)   183 (15.9%)   195 (15.9%)   211 (15.2%)   210 (13.3%)   200 (13.3%)   1173
  50--59     148 (15.0%)   159 (13.9%)   196 (16.0%)   189 (13.6%)   281 (17.8%)   233 (15.5%)   1206
  60--69     235 (23.8%)   290 (25.3%)   323 (26.4%)   353 (25.4%)   376 (23.9%)   422 (28.1%)   1999
  70--79     230 (23.3%)   277 (24.2%)   301 (24.6%)   388 (27.9%)   432 (27.4%)   403 (26.8%)   2031
  ≥80        66 (6.7%)     109 (9.5%)    108 (8.8%)    156 (11.2%)   175 (11.1%)   173 (11.5%)   787
  Total      986           1147          1226          1389          1576          1504          7828

Among all the causes of death (8285), 6630 cases (80.0%) were completely registered. The major causes of death were cardiovascular diseases (24.5%, 1623/6630), sudden death (21.8%), cerebrovascular diseases (21.7%), infections (11.7%), and gastrointestinal bleeding (6.4%) ([Figure 2](#F0002){ref-type="fig"}). Heart-failure accounted for 34.4% (558 of 1623) in cardiovascular diseases, and cerebral hemorrhage accounted for 75.1% (1082 of 1440) in cerebrovascular diseases.

![The constitution of causes of death for ESRD-HD patients from 2011 to 2016 (%).](IRNF_A_1612429_F0002_C){#F0002}

Discussion {#s0010}
==========

ESRD affects a large population, leading to a high prevalence worldwide \[[@CIT0005],[@CIT0006]\]. Zhang et al. showed that the prevalence of chronic kidney disease (CKD) was 10.8% in China, but its prevalence was 18.3% in Sichuan province \[[@CIT0007]\]. According to other reports, 2% CKD patients have progressed to ESRD \[[@CIT0008]\]. Current treatment for ESRD includes HD, PD, and kidney transplantation \[[@CIT0009],[@CIT0010]\]. In most of the countries and regions, HD is the major treatment for ESRD patients. In China, HD is still considered the major strategy for ESRD treatment. Dialysis patients have lower survival rates when compared to the general population \[[@CIT0011]\]. The mortality rate of HD patients is 6.1--7.8 folds in the general population of same age, and the USRDS data showed that the survival rate of 5 year-dialysis patients is as low as 49% \[[@CIT0014]\]. So, ESRD has become a significant public health issue worldwide.

Our study demonstrated the trends of increasing ESRD incidence in Sichuan population. The results showed that the annual incidence of new HD patients from 2011 to 2016 was 61.84, 73.75, 78.04, 66.04, 72.61, and 60.98 pmp, respectively. Generally, the annual incidence of new HD patients in Sichuan is lower than the well-developed areas of China such as Beijing (99.9--153.4 pmp) \[[@CIT0015]\], Shanghai (114.8 pmp) \[[@CIT0016]\], and higher than the developing areas such as Shanxi province (46.62--62.93 pmp) \[[@CIT0017]\] and Hainan province (44.2--64.7 pmp) \[[@CIT0018]\].

The possible reasons for these differences could be due to different financial and health care levels. Also, there could be loss of some information during the registration process of the patients, leading to underestimation of the annual incidence.

We found that the incidence of HD patients with ESRD-HD in Sichuan province was different between males and females. The sex ratio was 1.5:1 (male:female). This was consistent with other reports, where there were 1.3 million females and 1.7 million males who were undergoing treatment with dialysis. It should be noted that the women's access to medical care in many countries was substantially limited due to lack of universal health coverage, high health care expenses, low income \[[@CIT0019]\], as well as women's social roles as non-wage earners in some patriarchal societies. Biological factors responsible for higher male prevalence rates for dialysis included the damaging effects of testosterone in men \[[@CIT0020]\]. Due to the protective effects of estrogen in women, the incidence rate of ESRD-HD is lower compared to men \[[@CIT0020]\].

Our study demonstrated that the elderly group included more number of new HD patients. This might be due to the aging of population in both developed as well as undeveloped countries and areas, and have chosen the option of HD for treatment. Indeed, we noticed that chronic glomerulonephritis, diabetic nephropathy, and hypertensive nephrosclerosis were the major causes of ESRD-HD in Sichuan province. Unlike the well developed countries, glomerulonephritis is the first cause of CKD in China. Among the patients who are undergoing dialysis, glomerulonephritis accounted for the highest cause, followed by diabetic nephropathy \[[@CIT0021]\]. Barsoum reported that the high prevalence of bacterial and viral infection affect the kidney; therefore, chronic glomerulonephritis currently is the principal cause of CKD in developing countries such as China, India, and Egypt \[[@CIT0022]\]. It is worth noting that the histologic types of glomerulonephritis in the developing countries vary considerably. IgA nephropathy predominates in China and it accounts for 37--58% of biopsy-proven primary glomerulonephritis \[[@CIT0023]\]. However, we found that the percentage of patients with chronic glomerulonephritis is descending and that of diabetic nephropathy is rising. With the changing way of life in China, the incidence of diabetes is also rising, and currently China is ranked in the first place in the world. Unlike the western countries, most of the diabetic patients in China are young and middle-aged, and these patients are exposed to high doses of blood glucose for a longer period, causing more damage to the kidney \[[@CIT0021]\].

Our study showed that the annual mortality rate of ESRD-HD was 113.20, 91.25, 73.02, 68.56, 68.57, and 58.39 per 1000 person-years from 2011 to 2016, which showed a descending trend. This was consistent with the USRDS data from the US \[[@CIT0001]\].

Moreover, our results showed that death caused by cardiovascular diseases was declining. As known, cardiovascular diseases are the leading causes of mortality in ESRD-HD patients. So, individuals should pay more and more attention to the cardiovascular diseases. As the number of deaths induced by cardiovascular diseases decrease, the mortality rates of HD patients reduce \[[@CIT0024]\].

Finally, our study showed that the elderly HD patients accounted for 61.5% of the total death population. Dialysis outcomes and practice patters (DOPP) reported that the HD patients of \>65 years have a mortality risk of 100% higher than the younger population \[[@CIT0025]\]. So, more attention should be paid to this age group.

In conclusion, the epidemiological manifestations and pathogenesis analysis of HD patients with ESRD-HD, mortality rates and causes of ESRD-HD in southwest of China, Sichuan province were presented. These data suggested for the urgent development and implementation of effective ESRD prevention strategies, especially in the elderly and diabetic nephropathy patients.
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